(Q47771396)

English

Identification of multiple mechanisms of resistance to vemurafenib in a patient with BRAFV600E-mutated cutaneous melanoma successfully rechallenged after progression.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

Identification of multiple mechanisms of resistance to vemurafenib in a patient with BRAFV600E-mutated cutaneous melanoma successfully rechallenged after progression. (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

1 reference

based on heuristic

inferred from title

4

object named as

Johann Weber

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

Olivier Michielin

10

object named as

Olivier Michielin

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

author name string

Emanuela Romano

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

Sylvain Pradervand

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

Alexandra Paillusson

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

Keith Harshman

5

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

Katja Muehlethaler

6

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

Daniel Speiser

7

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

Solange Peters

8

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

Donata Rimoldi

9

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

language of work or name

0 references

publication date

15 August 2013

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

Clinical Cancer Research

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

19

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

5749-5757

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

20

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE09626

Mutations of the BRAF gene in human cancer

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE00766

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CCR.2010.11.023

Identifiers

10.1158/1078-0432.CCR-13-0661

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/23948972

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47771396&oldid=1647158398"